Cancer Epidemiology Biomarkers and Prevention Q1 Unclaimed
Cancer Epidemiology Biomarkers and Prevention is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 215. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system The scope of the journal is focused on Oncology, Cancer, Epidemiology, Genetics, Molecular Eidemiology, Biomarkers. It has an SJR impact factor of 1,688 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,688.
Cancer Epidemiology Biomarkers and Prevention focuses its scope in these topics and keywords: cancer, breast, hpv, colorectal, risk, diagnosis, lung, late, type, highrisk, ...
Type: Journal
Type of Copyright: CC BY-NC-ND
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
1,688
SJR Impact factor215
H Index218
Total Docs (Last Year)916
Total Docs (3 years)8212
Total Refs3103
Total Cites (3 years)868
Citable Docs (3 years)3.08
Cites/Doc (2 years)37.67
Ref/DocOther journals with similar parameters
Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1
Compare this journals
Aims and Scope
Best articles by citations
Reduced Plasma Level of CXC Chemokine Ligand 7 in Patients with Pancreatic Cancer
View more-3 and -6 Polyunsaturated Fatty Acid Intakes and the Risk of Breast Cancer in Mexican Women: Impact of Obesity Status
View moreCirculating Inflammation Markers and Risk of Epithelial Ovarian Cancer
View moreModifiable Risk Factors Associated with Clearance of Type-Specific Cervical Human Papillomavirus Infections in a Cohort of University Students
View moreMetformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer
View moreFeasibility Study for Collection of HER2 Data by National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program Central Cancer Registries
View moreSerum Calcium and Serum Albumin Are Biomarkers That Can Discriminate Malignant from Benign Pelvic Masses
View moreEffect of Mammography on Breast Cancer Risk in Women with Mutations in BRCA1 or BRCA2
View moreShift Work, Chronotype, and Melatonin Patterns among Female Hospital Employees on Day and Night Shifts
View moreAssociations between Arsenic Exposure and Global Posttranslational Histone Modifications among Adults in Bangladesh
View more"Journals Should Publish All ""Null"" Results and Should Sparingly Publish ""Positive"" Results"
View moreDeterminants of Prevalence, Acquisition, and Persistence of Human Papillomavirus in Healthy Mexican Military Men
View moreAnal Human Papillomavirus Infection in Women and Its Relationship with Cervical Infection
View moreFred F. Kadlubar: In Memoriam (1946-2010)
View moreImpact of Neighborhood and Individual Socioeconomic Status on Survival after Breast Cancer Varies by Race/Ethnicity: The Neighborhood and Breast Cancer Study
View moreTea Consumption and Risk of Breast Cancer
View moreDevelopment and Validation of a New, Sensitive Immunochemical Assay for O6-Methylguanine in DNA and Its Application in a Population Study
View moreGenetic Polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the Risk of Advanced Precancerous Gastric Lesions in a Chinese Population
View moreCutting Cost and Increasing Access to Colorectal Cancer Screening: Another Approach to Following the Guidelines
View moreChlamydial Antibodies and Risk of Prostate Cancer
View morePlasma Antibodies against Chlamydia trachomatis, Human Papillomavirus, and Human Herpesvirus Type 8 in Relation to Prostate Cancer: A Prospective Study
View moreUptake of Risk-Reducing Surgery in Unaffected Women at High Risk of Breast and Ovarian Cancer Is Risk, Age, and Time Dependent
View moreEvaluation of an ELISA for p16INK4a as a Screening Test for Cervical Cancer
View moreEpigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
View more
Comments